121 related articles for article (PubMed ID: 12621574)
21. The Cataract National Dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medications.
Benzimra JD; Johnston RL; Jaycock P; Galloway PH; Lambert G; Chung AK; Eke T; Sparrow JM;
Eye (Lond); 2009 Jan; 23(1):10-6. PubMed ID: 18259210
[TBL] [Abstract][Full Text] [Related]
22. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
Garwood CL; Corbett TL
Ann Pharmacother; 2008 Apr; 42(4):523-32. PubMed ID: 18334606
[TBL] [Abstract][Full Text] [Related]
23. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery.
Katz J; Feldman MA; Bass EB; Lubomski LH; Tielsch JM; Petty BG; Fleisher LA; Schein OD;
Ophthalmology; 2003 Sep; 110(9):1784-8. PubMed ID: 13129878
[TBL] [Abstract][Full Text] [Related]
24. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
[TBL] [Abstract][Full Text] [Related]
25. Controversies in perioperative management of blood thinners in dermatologic surgery: continue or discontinue?
Alcalay J; Alkalay R
Dermatol Surg; 2004 Aug; 30(8):1091-4; discussion 1094. PubMed ID: 15274698
[TBL] [Abstract][Full Text] [Related]
26. Maintaining patency of tunneled hemodialysis catheters--efficacy of aspirin compared to warfarin.
Obialo CI; Conner AC; Lebon LF
Scand J Urol Nephrol; 2003; 37(2):172-6. PubMed ID: 12745728
[TBL] [Abstract][Full Text] [Related]
27. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
28. Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment.
Milic DJ; Perisic ZD; Zivic SS; Stanojkovic ZA; Stojkovic AM; Karanovic ND; Krstic NH; Salinger SS
Europace; 2005 Jul; 7(4):374-9. PubMed ID: 15944096
[TBL] [Abstract][Full Text] [Related]
29. [Warfarin in the treatment of antiphospholipid syndrome].
Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
[TBL] [Abstract][Full Text] [Related]
30. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
31. Subdural hematoma after a fall in an elderly patient taking high-dose omega-3 fatty acids with warfarin and aspirin: case report and review of the literature.
McClaskey EM; Michalets EL
Pharmacotherapy; 2007 Jan; 27(1):152-60. PubMed ID: 17192169
[TBL] [Abstract][Full Text] [Related]
32. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
Abdelhafiz AH; Wheeldon NM
Clin Ther; 2004 Sep; 26(9):1470-8. PubMed ID: 15531009
[TBL] [Abstract][Full Text] [Related]
33. Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.
Colli A; Mestres CA; Castella M; Gherli T
J Heart Valve Dis; 2007 Nov; 16(6):667-71. PubMed ID: 18095518
[TBL] [Abstract][Full Text] [Related]
34. Risk of thromboembolism with short-term interruption of warfarin therapy.
Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
[TBL] [Abstract][Full Text] [Related]
35. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
36. Excessive prolongation of prothrombin time among patients treated with warfarin and admitted to the emergency room.
Habib G; Nashashibi M; Khateeb A; Goichman S; Kogan A
Eur J Intern Med; 2008 Mar; 19(2):129-34. PubMed ID: 18249309
[TBL] [Abstract][Full Text] [Related]
37. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
[TBL] [Abstract][Full Text] [Related]
39. Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.
Herlitz J; Holm J; Peterson M; Karlson BW; Haglid Evander M; Erhardt L;
Eur Heart J; 2004 Feb; 25(3):232-9. PubMed ID: 14972424
[TBL] [Abstract][Full Text] [Related]
40. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
